On July 14, 2022, Andrew L. Pecora, M.D., F.A.C.P., President of Celularity Inc. notified the board of directors of his decision to resign as President effective as of August 31, 2022. Dr. Pecora's decision to resign was not due to any disagreement with Celularity on any matter, or relating to its operations, policies, or practices. Celularity expects to enter into a consulting agreement with Dr. Pecora whereby Dr. Pecora will continue to assist Celularity during a transition period and also serve as co-Chair of Celularity's Scientific Advisory Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.205 USD | -1.38% | -1.38% | +29.55% |
1st Jan change | Capi. | |
---|---|---|
+29.55% | 69.81M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- CELU Stock
- News Celularity Inc.
- Celularity Inc. Announces the Resignation of Andrew L. Pecora as President, Effective from August 31, 2022